Physostigmine. from the God's judgment bean to modern antidote and therapeutic agent
Walter, K.; Aschoff, J.C.
Medizinische Monatsschrift für Pharmazeuten 19(9): 252-260
1996
ISSN/ISBN: 0342-9601 PMID: 8975105 Document Number: 466960
Document emailed within 1 workday
Related Documents
Rygnestad, T. 1992: Development of physostigmine from a poisonous plant to an antidote. one of the most important drugs in the development of modern medicine? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 112(10): 1300-1303Navrátil, J.; Sklenovský, A.; Chmela, Z.; Rypka, M. 1989: Perspectives of physostigmine as antidote by toluene intoxication Acta Universitatis Palackianae Olomucensis Facultatis Medicae 121: 267-270
Daunderer, M. 1980: Therapy in poisonings--antidote 7: the antidotes physostigmine salicylate, toluidin blue Fortschritte der Medizin 98(7): 245-248
Simonenko, V.E.; Sarmanaev, S.Kh.; Kovalev, E.V.; Sarmanaeva, R.R.; Kukhanov, A.V. 2014: Modern approaches to the formation of antidote stocks at medical institutions in Russia and foreign countries Voenno-Meditsinskii Zhurnal 335(11): 22-26
Borrello, M. 2011: Alcune riflessioni sul giudizio. La relazione tra giudizio giudiziario e giudizio storico - Some Reflections on Judgment. The Relationship between Judicial Judgment and Historical Judgment Rivista Internazionale di Filosofia del Diritto 88(2): 231-264
Knapp, S.; Wardlow, M.L.; Albert, K.; Waters, D.; Thal, L.J. 1991: Correlation between plasma physostigmine concentrations and percentage of acetylcholinesterase inhibition over time after controlled release of physostigmine in volunteer subjects Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(2): 400-404
Andersson, P.O.; Jacobsson, S.; Wadenvik, H. 1998: A forgotten fraudulent bean--a case of favism. Fava bean may cause life-threatening hemolysis in predisposed persons Lakartidningen 95(23): 2712-2714
Benshimol, A.L.; de Stein, R.I.; Márquez, C.G.; Jaffé, W.G. 1985: Biochemical and nutritional value of seeds of the lima bean (Phaseolus lunatus) in comparison with those of the common bean (Phaseolus vulgaris) Archivos Latinoamericanos de Nutricion 35(1): 70-79
Pace, V.; Artico, M.; Ciccariello, M.; Bonanni, G. 1990: The current physiopathological, diagnostic, clinical and therapeutic considerations of peptic ulcer. a comparison between traditional and modern therapeutic methods Minerva Dietologica e Gastroenterologica 36(2): 63-75
Smuckler, E.A. 1985: Hepatitis, the delta agent and modern virology Archives of Pathology and Laboratory Medicine 109(5): 394
Muller, B. 2011: Access to the Courts of the Member States for NGOs in Environmental Matters under European Union Law: Judgment of the Court of 12 May 2011 -- Case C-115/09 Trianel and Judgment of 8 March 2011 -- Case C-240/09 Lesoochranarske Zoskupenie Journal of Environmental Law 23(3): 505-516
Peeters, J.P. 1973: Value of a new therapeutic agent, diosmine, in proctology Bruxelles Medical 53(10): 591-594
Singh, R. 2002: The importance of exercise as a therapeutic agent Malaysian Journal of Medical Sciences: Mjms 9(2): 7-16
Heynen, U. 1971: Pimafucin--a polyvalent vaginal therapeutic agent Zeitschrift für Allgemeinmedizin 47(15): 829-830
Bouffioux, C.; de Leval, J. 1980: Estracyt, new therapeutic agent for cancer of the prostate Revue Medicale de Liege 35(24): 865-870
Van Zyl, J.J. 1973: Gas gangren, the modern therapeutic approach South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie 11(4): 181-185
Muniz, C.E.; Ogburn, B.R.; Ampbell, D.R. 1971: Lithium as a therapeutic agent in the treatment of manicdepressive illness Southern Medical Journal 64(2): 177-179
Starks, G.C. 1985: Diagnostic and therapeutic applications of a betamimetic agent in infertility Missouri Medicine 82(1): 21-23
Chatani, Y. 2005: Minodronic acid hydrate as a new therapeutic agent for osteoporosis Clinical Calcium 15(1): 9-14
Lipecka, K. 1989: Therapeutic use of superoxide dismutase as an anti-inflammatory agent Polski Tygodnik Lekarski 44(14): 339-340